Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
3.91
0.02 (0.51%)
At close: Sep 18, 2025, 3:59 PM

Clearside Biomedical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.66M 8.23M 1.33M 29.57M
Cost of Revenue
149K 355K 204K 178K
Gross Profit
1.51M 7.87M 1.12M 29.57M
Operating Income
-28.88M -24.84M -30.28M -627K
Interest Income
1.46M 1.72M 669K n/a
Pretax Income
-34.35M -32.48M -32.95M 376K
Net Income
-34.35M -32.48M -32.95M 376K
Selling & General & Admin
11.81M 11.87M 11.77M 11.66M
Research & Development
18.59M 20.85M 19.63M 18.54M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
30.4M 32.72M 31.4M 30.2M
Interest Expense
9.78M 9.36M 3.34M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
30.55M 33.07M 31.6M 30.2M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
4.92M 4.12M 4.01M 3.9M
Shares Outstanding (Diluted)
4.92M 4.12M 4.01M 3.99M
EPS (Basic)
-7.05 -7.95 -8.25 0.10
EPS (Diluted)
-7.05 -7.95 -8.25 0.09
EBITDA
-24.35M -23.06M -29.46M 554K
EBIT
-24.57M -23.13M -29.61M 376K
Depreciation & Amortization
226K 67K 145K 178K